Efficacy and Safety of Hormonal Therapies for Acne: A Narrative Review. [PDF]
Tommasino N +3 more
europepmc +1 more source
Study protocol for a multicentre, randomised, double-blinded, placebo-controlled, multi-arm, multi-stage, trial of SpironolacTone and famciclOovir in the treatment of Progressive Multiple Sclerosis to prevent disability progression: the STOP-MS trial. [PDF]
Ward K +29 more
europepmc +1 more source
Finerenone versus spironolactone in patients with chronic kidney disease and type 2 diabetes: a target trial emulation. [PDF]
Wang CA +7 more
europepmc +1 more source
Cardiovascular Benefits of Spironolactone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from a Win Ratio Analysis of the TOPCAT Trial. [PDF]
Nguyen DV, Nguyen HTT.
europepmc +1 more source
Nonsteroidal mineralocorticoid receptor antagonists and cardiovascular events in type 2 diabetes: a retrospective study. [PDF]
Chen YH +4 more
europepmc +1 more source
Regulation of Klotho Production by Mineralocorticoid Receptor Signaling in Renal Cell Lines. [PDF]
Kohm E, Feger M, Föller M.
europepmc +1 more source
Effects of Spironolactone (Aldosterone Antagonist) on Electrolyte and Water Content of the Cauda Epididymidis and Fertility of Male Rats [PDF]
Pyd Wong, W. M. Lee
openalex +1 more source
Plasma atrial natriuretic factor in patients with cirrhosis [PDF]
Arendt, Rainer M. +5 more
core

